Evidence map›Paper›PMID 29450979›Full record

ArticleJournal of clinical hypertension (Greenwich, Conn.)2018

Guidance on home blood pressure monitoring: A statement of the HOPE Asia Network.

Kazuomi Kario, Sungha Park, Peera Buranakitjaroen, Yook-Chin Chia, Chen-Huan Chen, Romeo Divinagracia, Satoshi Hoshide, Jinho Shin, Saulat Siddique, Jorge Sison and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical hypertension (Greenwich, Conn.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 67 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Target blood pressure and control status in Asia.Journal of clinical hypertension (Greenwich, Conn.) · 2020
    Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Hypertension and stroke in Asia: A comprehensive review from HOPE Asia.Journal of clinical hypertension (Greenwich, Conn.) · 2021
    Review
  17. Review
  18. Review
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 16 institutions in 13 countries.

Kazuomi KarioDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.ORCID 0000-0002-8251-4480
Sungha ParkDivision of Cardiology, Cardiovascular Hospital, Yonsei Health System, Seoul, Korea.
Peera BuranakitjaroenDepartment of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Yook-Chin ChiaDepartment of Primary Care Medicine, Faculty of Medicine, University of Malaya Kuala, Lumpur, Malaysia.
Chen-Huan ChenDepartment of Medicine, Faculty of Medicine National Yang-Ming University, Taipei, Taiwan.
Romeo DivinagraciaUniversity of the East Ramon Magsaysay Memorial Medical Center Inc, Quezon City, Philippines.
Satoshi HoshideDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.ORCID 0000-0001-7541-5751
Jinho ShinFaculty of Cardiology Service, Hanyang University Medical Center, Seoul, Korea.
Saulat SiddiquePunjab Medical Center, Lahore, Pakistan.
Jorge SisonSection of Cardiology, Department of Medicine, Medical Center Manila, Manila, Philippines.
Arieska Ann SoenartaDepartment Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center Harapan Kita, Jakarta, Indonesia.
Guru Prasad SogunuruApollo Hospitals, Chennai, India.
Jam Chin TayDepartment of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore.
Yuda TuranaDepartment of Neurology, Faculty of Medicine, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia.
Lawrence WongDepartment of Medicine & Therapeutics, Division of Neurology, Chinese University of Hong Kong, Hong Kong.
Yuqing ZhangDivisions of Hypertension and Heart Failure, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Ji-Guang WangDepartment of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.ORCID 0000-0001-8511-1524
Jichi Medical University · JPApollo Hospitals · INAtma Jaya Catholic University of Indonesia · IDChinese Academy of Medical Sciences & Peking Union Medical College · CNChinese General Hospital and Medical Center · PHChinese University of Hong Kong · HKHanyang University Medical Center · KRNational Yang Ming Chiao Tung University · TWPelita Harapan University · IDPunjab Medical Center · PKRuijin Hospital · CNSiriraj Hospital · THTan Tock Seng Hospital · SGUniversity of Malaya · MYUniversity of the East Ramon Magsaysay Memorial Medical Center · PHYonsei University Health System · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertension is an important modifiable cardiovascular risk factor and a leading cause of death throughout Asia. Effective prevention and control of hypertension in the region remain a significant challenge despite the availability of several regional and international guidelines. Out-of-office measurement of blood pressure (BP), including home BP monitoring (HBPM), is an important hypertension management tool. Home BP is better than office BP for predicting cardiovascular risk and HBPM should be considered for all patients with office BP ≥ 130/85 mm Hg. It is important that HBPM is undertaken using a validated device and patients are educated about how to perform HBPM correctly. During antihypertensive therapy, monitoring of home BP control and variability is essential, especially in the morning. This is because HBPM can facilitate the choice of individualized optimal therapy. The evidence and practice points in this document are based on the Hypertension Cardiovascular Outcome Prevention and Evidence (HOPE) Asia Network expert panel consensus recommendations for HBPM in Asia.

Indexed as

Antihypertensive AgentsBlood Pressure Monitoring, AmbulatoryGuideline AdherenceHumansHypertensionPatient CompliancePrecision MedicineAntihypertensive Agentsblood pressure controlclinical practiceguidelineshome blood pressure monitoringhypertensionPfizer

Identifiers

PMID29450979
PMCPMC8031139
OpenAlexW2792988835

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.